Company Events

Company Dynamics

04-06

2020

Rybelsus® (oral semaglutide) approved for the treatment of adults with type 2 diabetes in the EU

4 April 2020 - Novo Nordisk today announced that the European Commission (EC) has granted marketing authorisation for Rybelsus® (oral semaglutide), for the treatment of adults with insufficiently controlled type 2 diabet……

03-29

2020

ViiV Healthcare announces first global regulatory approval of CABENUVA; the first complete, long-acting, regimen for the treatment of HIV

March 20, 2020--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that Health Canada has approved CABENUVA, the first and onl……

03-06

2020

To win the battle against Corona virus, Dorra is on the way.

A sudden epidemic affected all the people nationwide, who made every preparation for the war in this war without smoke.It’s Dorra’s responsibility to fight with the epidemic when it occurred. Dow Pharmaceutical uses inte……

12-27

2019

the second healthy activity -Tai Chi

Tai Chi has a long history in China and is a national intangible cultural heritage. Tai Chi has been favored by many people for its practical value and physical fitness. Meanwhile, Tai Chi has a deep cultural connotation……

10-25

2019

Dorra won the "Sunshine Power Award" from Jiangsu Youth Foundation

Ten years of public welfare road, a long-term public welfare. In October, the Inspiring Sunshine fundation of the Jiangsu Youth Development Foundation officially celebrated its 20th anniversary. Invited by the foundation……

09-27

2019

Training and Development

 ‘Operating Capital Management’ on Sept.2ndTrainee: Supply Chain Management Dept., Sales Dept., Financial Dept.Achievement: Operating capital management is the core of a company's financial operations. We learne……

< 1 2 3 4 5 >

Copyright Nanjing Dorra Pharmaceutical Technology Co.,Ltd. @ 2018 China All Rights Reserved